These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17074952)

  • 21. Low-cost contingency management in community clinics: delivering incentives partially in group therapy.
    Alessi SM; Hanson T; Wieners M; Petry NM
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):293-300. PubMed ID: 17563216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers.
    Lisa P; Felicia K; Laura H; Daniela K; Marlies R; Stefanie N; Maik SJ; Anne S; Maximilian S; Kirsi M; Michael S; Gabi K
    Psychiatry Res; 2019 Oct; 280():112505. PubMed ID: 31382181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
    Stitzer ML; Petry N; Peirce J; Kirby K; Killeen T; Roll J; Hamilton J; Stabile PQ; Sterling R; Brown C; Kolodner K; Li R
    J Consult Clin Psychol; 2007 Oct; 75(5):805-11. PubMed ID: 17907862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A contingency management intervention for adolescent marijuana abuse and conduct problems.
    Kamon J; Budney A; Stanger C
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):513-21. PubMed ID: 15908833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spend today, clean tomorrow: predicting methamphetamine abstinence in a randomized controlled trial.
    Ling Murtaugh K; Krishnamurti T; Davis AL; Reback CJ; Shoptaw S
    Health Psychol; 2013 Sep; 32(9):958-66. PubMed ID: 24001246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Give them prizes, and they will come: contingency management for treatment of alcohol dependence.
    Petry NM; Martin B; Cooney JL; Kranzler HR
    J Consult Clin Psychol; 2000 Apr; 68(2):250-7. PubMed ID: 10780125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential benefits of quetiapine in the treatment of substance dependence disorders.
    Sattar SP; Bhatia SC; Petty F
    J Psychiatry Neurosci; 2004 Nov; 29(6):452-7. PubMed ID: 15644986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals.
    Rawson RA; McCann MJ; Flammino F; Shoptaw S; Miotto K; Reiber C; Ling W
    Addiction; 2006 Feb; 101(2):267-74. PubMed ID: 16445555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia.
    Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R
    Drug Alcohol Rev; 2024 Jul; 43(5):1313-1322. PubMed ID: 38704742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy.
    Galloway GP; Polcin D; Kielstein A; Brown M; Mendelson J
    J Psychoactive Drugs; 2007 Nov; Suppl 4():393-400. PubMed ID: 18286727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.
    Farronato NS; Dürsteler-Macfarland KM; Wiesbeck GA; Petitjean SA
    J Addict Dis; 2013; 32(3):274-87. PubMed ID: 24074193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rewarding early abstinence in Veterans Health Administration addiction clinics.
    Hagedorn HJ; Noorbaloochi S; Simon AB; Bangerter A; Stitzer ML; Stetler CB; Kivlahan D
    J Subst Abuse Treat; 2013 Jul; 45(1):109-17. PubMed ID: 23453480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of voucher exchanges between criminal justice involved and noninvolved participants enrolled in voucher-based contingency management drug abuse treatment programs.
    Roll JM; Prendergast ML; Sorensen K; Prakash S; Chudzynski JE
    Am J Drug Alcohol Abuse; 2005; 31(3):393-401. PubMed ID: 16161725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contingency management treatment for methamphetamine use disorder in South Africa.
    Okafor CN; Stein DJ; Dannatt L; Ipser J; van Nunen LJ; Lake MT; Krishnamurti T; London ED; Shoptaw S
    Drug Alcohol Rev; 2020 Mar; 39(3):216-222. PubMed ID: 31863530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.